Despite warnings, potentially inappropriate CNS-active medications are commonly prescribed to older adults — especially those with cognitive impairment — highlighting missed opportunities for safer ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

The team’s research provides compelling evidence for the brain’s influence on physiology. A deeper understanding of this mind ...

Please provide your email address to receive an email when new articles are posted on . An Ohio-based medical device company has secured $85 million in financing to advance a pain management system ...

MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. The neuro-focused company is penning a strategic collaboration meant to develop new therapies for ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

- Portfolio available in 60+ markets and deepens our CNS footprint in Brazil, South Africa, France and Italy BASILDON, England--(BUSINESS WIRE)--PRESS RELEASE – FOR TRADE, BUSINESS AND MEDICAL MEDIA ...

Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We spend one-quarter to one-third of our lives sleeping, but while we rest, the brain remains ...

When you’re short on sleep and your focus suddenly drifts, your brain may be briefly slipping into cleanup mode. Scientists ...